Healthcare -
Biotechnology - NASDAQ - US
$ 0.7738
1.91 %
$ 132 M
Market Cap
-1.93
P/E
MCRB - STOCK-BASED COMPENSATION
Stock-based Compensation MCRB - Seres Therapeutics, Inc.
34.1 M
LAST VALUE
29.86%
2 YEAR CAGR
15.43%
5 YEAR CAGR
66.44%
10 YEAR CAGR